Sign in or create a free account to view this dataset's chart and data table.
Key Takeaway
- Antibiotic medicines recorded a CAGR of 1% between FY 2019–20 and FY 2024–25, reflecting limited growth. The category includes intramammary, oral and parenteral antibiotics, sulfonamides and other anti-infective agents. The low growth rate indicates that sales remained relatively stable over the period.
About This Dataset
Annual sales data for animal health antibiotic products, including intramammary, oral and parenteral antibiotics, other anti-infective agents and sulfonamides. These products are used in the treatment and management of bacterial infections in animals. The dataset presents aggregated sales by financial year from 1 July to 30 June.
Methodology
Sign in or create a free account to view this dataset's methodology and sources.
Available formats: Excel, CSV, PNG, PDF.
Transform Data Into Better Business Decisions
Join organizations that rely on statSCALAR for trusted market intelligence, industry statistics, commodity insights and enterprise research.